Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller at Pfizer Inc., reported the acquisition of 54 phantom stock units through the Pfizer Supplemental Savings Plan on April 15, 2024.

Summary

• On April 15, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 54 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the derivative security was $25.91.
• Following the transaction, Ms. Damico directly owns 27,864 derivative securities.
• The phantom stock units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing indicating an executive's participation in a company savings plan. It's neutral to slightly positive as it reflects alignment of interests between management and shareholders.

Positives

• The acquisition of phantom stock units aligns Ms. Damico's interests with those of Pfizer shareholders.
• The Pfizer Supplemental Savings Plan provides a mechanism for employees to accumulate wealth tied to the company's performance.

Future Outlook

The phantom stock units will be settled in cash following Ms. Damico's separation from service or may be transferred into an alternative investment account.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. This filing indicates participation in a company savings plan, which is a common practice.

Comparison to Industry Standards

• Many large pharmaceutical companies like Johnson & Johnson (JNJ) and Merck & Co. (MRK) offer similar supplemental savings plans to their executives.
• Phantom stock plans are a common form of executive compensation, aligning management's interests with shareholder value, similar to stock options or restricted stock units.
• The reporting requirements under Section 16(a) of the Securities Exchange Act are standard practice for all publicly traded companies in the United States.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the executive's interests with the company's performance.
• Employees participating in the Supplemental Savings Plan benefit from the opportunity to accumulate wealth tied to Pfizer's stock performance.

Key Dates